The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.
Kids more often get the psychiatric care they need if they live in states that mandate insurance coverage for child mental health care, a new study confirms.
